Skip to main content
Carina Namih

Carina Namih

Partner, Plural
Carina is a partner at Plural, the early-stage investment fund that backs the most ambitious founders on a mission to change the world through technology. She has been an investor for over a decade. Her most recent investments are Robin AI, a generative AI copilot for lawyers, and Sano Genetics, a software platform powering precision medicine trials. Previously, Carina was the CEO and co-founder of HelixNano - one of the first AI-driven biotechs, now pivotal in the fight against Covid and cancer. She is a trustee of The Alan Turing Institute.